Volume 1.18 | Jul 17

Immunology of Infectious Disease News 1.18 July 17, 2013
Immunology of Infectious Disease News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Immunology of Infectious Disease News on Twitter
 
TOP STORY
Since Prior Flu Exposure Dictates Your Future Immune Response, New Vaccine Regiments Can Be Rationally Developed, Researchers Say
Scientists determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century. [Press release from The Wistar Institute discussing online prepublication in the Journal of Experimental Medicine] Press Release | Abstract
Hassle-Free PBMC Isolation in Just 15 Minutes
 
PUBLICATIONS (Ranked by impact factor of the journal)
B Cells Regulate Neutrophilia during Mycobacterium tuberculosis Infection and BCG Vaccination by Modulating the Interleukin-17 Response
The authors examined the mechanisms by which B cells regulate the host neutrophilic response upon exposure to mycobacteria and how neutrophilia may influence vaccine efficacy. To address these questions, a murine aerosol infection tuberculosis model and an intradermal ear BCG immunization mouse model, involving both the μMycobacterium tuberculosis strain and B cell-depleted C57BL/6 mice, were used. [PLoS Pathog] Full Article

CD40 Activation Rescues Antiviral CD8+ T Cells from Programmed Death 1-Mediated Exhaustion
The intrahepatic immune environment is normally biased towards tolerance. Nonetheless, effective antiviral immune responses can be induced against hepatotropic pathogens. To examine the immunological basis of this paradox researchers studied the ability of hepatocellularly expressed hepatitis B virus (HBV) to activate immunologically naïve HBV-specific CD8+ T cell receptor transgenic T cells after adoptive transfer to HBV transgenic mice. [PLoS Pathog] Full Article

Decreased Vδ2 γδ T Cells Associate with Liver Damage through Regulating Th17 Response in Chronic Hepatitis B Patients
γδ T cells comprise a small subset of T cells and play a protective role against cancer and viral infections; however, their precise role in patients with chronic hepatitis B remains unclear. Flow cytometry and immunofunctional assays were performed to analyze the impact of Vδ2 γδ T cells in 64 immune-activated patients, 22 immune-tolerant carriers and 30 healthy controls. [J Infect Dis] Abstract

Pathways of IL-1β Secretion by Macrophages Infected with Clinical Mycobacterium tuberculosis Strain
The authors investigated the primary pathways of interleukin (IL-1β) secretion in macrophages infected with a panel of 17 clinical M. tuberculosis isolates, representing Euro-American, Indo-Oceanic and East-Asian/Beijing lineages. They aimed to dissect the pathways involved in M. tuberculosis induced IL-1β secretion and to determine whether they are common to all clinical isolates. [Tuberculosis]
Abstract
| Press Release

An Attenuated Temperature-Sensitive Strain of Cytomegalovirus (tsm5) Establishes Immunity without Development of CD8+ T Cell Memory Inflation
Using murine cytomegalovirus, researchers showed that memory inflation of virus-specific CD8+ T cells is avoided if mice are infected with a replication defective virus called temperature-sensitive mutant 5 (tsm5), which carries an attenuating mutation within the DNA primase gene. Mice infected with tsm5 do generate primary T cell responses towards viral proteins but these do not amass to skew the memory repertoire of CD8+ T cells. [J Med Virol] Abstract

HIV

Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
Using high-resolution bacterial community profiling, the authors identified a dysbiotic mucosal-adherent community enriched in Proteobacteria and depleted of Bacteroidia members that was associated with markers of mucosal immune disruption, T cell activation, and chronic inflammation in HIV-infected subjects. [Sci Transl Med] Abstract | Press Release | Video

Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-Specific CD8 T Cells
Researchers investigated HIV-specific CD8 T cell responses in 85 patients with primary HIV infection or chronic (progressive and non-progressive) infection. The functional avidity of HIV-specific CD8 T cells was not different between patients with progressive and non-progressive chronic infection. [PLoS Pathog]
Full Article


Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery
The human immunodeficiency virus type 1 (HIV-1) PENNVAX®-B DNA vaccine is a mixture of three expression plasmids encoding HIV-1 Clade B Env, Gag, and Pol. The interleukin 12 (IL-12) DNA plasmid expresses human IL-12 proteins p35 and p40. Study subjects were healthy HIV-1-uninfected adults 18-50 years old. Four intramuscular vaccinations were given in HVTN 070, and three intramuscular vaccinations were followed by electroporation in HVTN 080. Cellular immune responses were measured by intracellular cytokine staining after stimulation with HIV-1 peptide pools. [J Infect Dis] Abstract | Press Release

The HIV-1 Protein Vpr Targets the Endoribonuclease Dicer for Proteasomal Degradation to Boost Macrophage Infection
Investigators identified the endoribonuclease Dicer as a target of HIV-1 Vpr-directed proteasomal degradation through CRL4DCAF1. They showed that HIV-1 Vpr inhibits short hairpin RNA function as expected upon reduction of Dicer levels. Dicer inhibits HIV-1 replication in T cells. [Virology] Abstract

Hepatitis B Virus (HBV)-Specific T-Cell Responses to Recombinant HBV Core Protein in Patients with Normal Liver Function and Co-Infected with Chronic HBV and Human Immunodeficiency Virus 1 (HIV-1)
Twenty-five patients with chronic HBV were enrolled in a cross-sectional study. A longitudinal study was also conducted in which follow-up was done at 3, 12, and 24 months, after acute HIV-1 infection, in 11 individuals who also had chronic HBV. Peripheral blood mononuclear cells were stimulated with recombinant HBV surface protein, core protein or gag peptide. IFN-gamma-secreting T cells were identified by ELISPOT assay. [Virol J] Abstract | Full Article

Don’t forget to subscribe to our sister publications: Human Immunology News and Immune Regulation News!

How Ex Vivo Models Drive Progress in HIV Research: Read the Research Profiles
 
REVIEWS
New Generation of Oral Mucosal Vaccines Targeting Dendritic Cells
Recent progress in understanding the molecular and cellular components of the mucosal immune system have allowed for the development of a novel mucosal vaccine platform utilizing specific dendritic cell-targeting peptides and orally administered lactobacilli to elicit efficient antigen specific immune responses against infections, including Bacillus anthracis in experimental models of disease. [Curr Opin Chem Biol] Abstract

Innate Immune Response to La Crosse Virus Infection
The authors discuss the current understanding of innate immune response in the context of viral pathogenesis and host susceptibility to La Crosse virus (LACV). In addition, they address the need for a clearer understanding of the early host-virus interactions in LACV infections as it relates to viral pathogenesis in the central nervous system. [J Neurovirol] Abstract

Visit our reviews page to see a complete list of reviews in the infectious disease research field.

Attend the World Vaccine Congress 2013 in Lille, France
 
SCIENCE NEWS
Inovio Pharmaceuticals’ Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study
Inovio Pharmaceuticals, Inc. announced that in a preclinical study of its influenza DNA vaccine against the virulent, newly emergent H7N9 flu virus, 100% of the vaccinated animals were protected against sickness and death when they were challenged with a lethal dose of H7N9 virus. The results from a study in mice demonstrated that Inovio’s vaccine generated not only hemagglutination inhibition-based protection against the H7N9 virus but also strong T-cell responses. [Press release from Inovio Pharmaceuticals, Inc. discussing research presented at the TEPIK/APACI International Influenza Symposium, Seoul] Press Release

From our sponsor:
View immunology lectures, protocols and other resources on the Human Immunology Portal.
 
INDUSTRY NEWS
Call for Volunteers as Malaria Vaccine Hopes Rise
Researchers at Griffith University’s Institute for Glycomics have been able to induce malaria immunity in animals and are now poised to advance first-stage human trials. A research team had taken a new approach to creating a vaccine for malaria; the mosquito-borne disease which afflicts a quarter of a billion people around the world. [Griffith University] Press Release

Medicago Announces Agreement to Be Acquired by Mitsubishi Tanabe Pharma in a Transaction Valued at $357 Million
Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and virus-like particles, announced that it has entered into a definitive arrangement agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) whereby MTPC will acquire all of the issued and outstanding common shares (Shares) of Medicago, other than the Shares currently held by Philip Morris Investments B.V. an affiliate of Philip Morris International Inc. and MTPC, for $1.16 in cash per Share. [Medicago Inc.] Press Release

Ruth Ruprecht, a Pioneer in AIDS-Related Research and Vaccines, and in Breast Cancer, Is Appointed to Virology Position at Texas Biomed
Ruth M. Ruprecht, M.D., Ph.D., a professor of medicine at Harvard Medical School and the Dana-Farber Cancer Institute in Boston, has been appointed to the position of Scientist and Director of the AIDS Research Program in the Department of Virology and Immunology at the Texas Biomedical Research Institute. [Texas Biomedical Research Institute] Press Release
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Influenza2013
September 17-19, 2013
Oxford, United Kingdom

Visit our events page to see a complete list of events in the infectious disease community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Pathogenesis of AIDS (Ulm University Medical Center)

Postdoctoral Position – Virus Host Interactions (CIBIO – University of Trento)

Postdoctoral Scientist – Humoral Responses against HIV (Seattle BioMed)

Director of Cell Processing Facility (S L Collins Associates, Inc.)

Research Scientist/Senior Research Officer – Monoclonal Antibodies (Bioprocessing Technology Institute/A*STAR)

Postdoctoral Fellow – Immune Responses against HIV (HIV Pathogenesis Program/University KwaZulu Natal & Ragon Institute of MGH, MIT and Harvard)

Junior or Senior Group Leader – Immunology/Infection/Inflammation (Center of Pathophysiology of Toulouse Purpan)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Immunology of Infectious Disease News?
Click here to submit!

Comments or Suggestions? Email info@connexoncreative.com with your feedback.
Learn more about Immunology of Infectious Disease News: Archives | Events | Contact Us